The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or ...

CardioFocus announced today that it initiated clinical trials for its next-generation pulsed field ablation (PFA) ...

The practice of routinely maintaining PIVC access has not only benefits but also risks. It’s due for a mindset shift, with ...